Teligent, Inc.

Company Listings from SPi: Teligent, Inc.

You are here: Home >> SPi Company Listings >> Teligent, Inc.

 

Teligent, Inc.

Website:
http://

Search for other references to "teligent" on SPi News

Latest Teligent, Inc. News

Teligent, Inc. Executes $120 Million Financing Agreement BUENA, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that on December 13, 2018 the Company entere...... 23:33 GMT Thursday 13th December 2018

Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-Q BUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having...... 22:15 GMT Friday 16th November 2018

Teligent, Inc. Announces $120 Million Financing Commitment From Ares BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitm...... 21:15 GMT Tuesday 13th November 2018

Teligent, Inc. Announces Third Quarter 2018 Results BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its fin...... 21:15 GMT Tuesday 13th November 2018

Teligent, Inc. to Hold Conference Call for Third Quarter 2018 Results BUENA, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a confer...... 13:30 GMT Monday 12th November 2018

Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018 BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London...... 12:45 GMT Friday 2nd November 2018

Teligent, Inc. Announces FDA Approval of Desoximetasone Ointment USP 0.05% BUENA, N.J., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approva...... 13:45 GMT Wednesday 24th October 2018

Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05% BUENA, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approva...... 13:45 GMT Wednesday 17th October 2018

Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05% BUENA, N.J., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approva...... 13:56 GMT Tuesday 2nd October 2018

Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ:TLGT) (“Teligent”), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride...... 21:30 GMT Thursday 16th August 2018

Buy Teligent, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us